Wegiel Barbara, Otterbein Leo E
Department of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center Boston, MA, USA.
Front Pharmacol. 2012 Mar 16;3:47. doi: 10.3389/fphar.2012.00047. eCollection 2012.
Biliverdin (BV) has emerged as a cytoprotective and important anti-inflammatory molecule. Conversion of BV to bilirubin (BR) is catalyzed by biliverdin reductase (BVR) and is required for the downstream signaling and nuclear localization of BVR. Recent data by others and us make clear that BVR is a critical regulator of innate immune responses resulting from acute insult and injury and moreover, that a lack of BVR results in an enhanced proinflammatory phenotype. In macrophages, BVR is regulated by its substrate BV which leads to activation of the PI3K-Akt-IL-10 axis and inhibition of TLR4 expression via direct binding of BVR to the TLR4 promoter. In this review, we will summarize recent findings on the role of BVR and the bile pigments in inflammation in context with its activity as an enzyme, receptor, and transcriptional regulator.
胆绿素(BV)已成为一种具有细胞保护作用的重要抗炎分子。BV向胆红素(BR)的转化由胆绿素还原酶(BVR)催化,这是BVR下游信号传导和核定位所必需的。我们和其他人最近的数据表明,BVR是急性损伤和伤害引起的先天免疫反应的关键调节因子,此外,缺乏BVR会导致促炎表型增强。在巨噬细胞中,BVR受其底物BV的调节,BV通过BVR与TLR4启动子的直接结合导致PI3K-Akt-IL-10轴的激活和TLR4表达的抑制。在这篇综述中,我们将结合BVR作为酶、受体和转录调节因子的活性,总结其在炎症中作用以及胆色素作用的最新研究结果。